We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
-6.74%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
AUM
$135M
AUM Growth
-$22.7M
Cap. Flow
-$4.24M
Cap. Flow %
-3.15%
Top 10 Hldgs %
60.19%
Holding
217
New
5
Increased
70
Reduced
111
Closed
26

Top Sells

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$246K
2
VFC icon
VF Corp
VFC
+$226K
3
ENPH icon
Enphase Energy
ENPH
+$221K
4
GIS icon
General Mills
GIS
+$218K
5
AVGO icon
Broadcom
AVGO
+$216K

Sector Composition

Rank Sector Weight
1 Healthcare 15.41%
2 Consumer Staples 7.39%
3 Consumer Discretionary 6.49%
4 Technology 5.62%
5 Industrials 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
101
Amgen
AMGN
$208B
$245K 0.18%
785
-84
-10% -$24.7K
VRSN icon
102
VeriSign
VRSN
$26.2B
$245K 0.18%
1,377
-284
-17% -$50.6K
EQIX icon
103
Equinix
EQIX
$101B
$244K 0.18%
323
-23
-7% -$17.5K
VTRS icon
104
Viatris
VTRS
$20.4B
$244K 0.18%
22,913
+3,530
+18% +$39K
OKE icon
105
Oneok
OKE
$57.2B
$243K 0.18%
2,985
-94
-3% -$7.51K
LLY icon
106
Eli Lilly
LLY
$1.02T
$243K 0.18%
268
-44
-14% -$35.2K
MNST icon
107
Monster Beverage
MNST
$94.3B
$242K 0.18%
4,849
+836
+21% +$44.3K
WMB icon
108
Williams Companies
WMB
$87.5B
$240K 0.18%
5,658
-936
-14% -$37.5K
MOH icon
109
Molina Healthcare
MOH
$10.2B
$239K 0.18%
805
+159
+25% +$54K
CNC icon
110
Centene
CNC
$30.7B
$239K 0.18%
3,608
+364
+11% +$26.5K
NEM icon
111
Newmont
NEM
$98.7B
$239K 0.18%
5,713
-1,294
-18% -$52.9K
TAP icon
112
Molson Coors Class B
TAP
$7.79B
$239K 0.18%
4,702
+1,020
+28% +$59K
PGR icon
113
Progressive
PGR
$123B
$238K 0.18%
1,147
-53
-4% -$11.1K
GS icon
114
Goldman Sachs
GS
$300B
$238K 0.18%
526
-89
-14% -$39.1K
NUE icon
115
Nucor
NUE
$58.6B
$238K 0.18%
1,504
+224
+18% +$38.9K
MS icon
116
Morgan Stanley
MS
$331B
$237K 0.18%
2,439
-289
-11% -$27.5K
ALL icon
117
Allstate
ALL
$68B
$237K 0.18%
1,484
-31
-2% -$5.17K
PFE icon
118
Pfizer
PFE
$143B
$237K 0.18%
8,463
-267
-3% -$7.35K
KO icon
119
Coca-Cola
KO
$377B
$237K 0.18%
3,720
-274
-7% -$17K
ABBV icon
120
AbbVie
ABBV
$443B
$237K 0.18%
1,379
+49
+4% +$8.12K
PEG icon
121
Public Service Enterprise Group
PEG
$38.2B
$237K 0.18%
3,209
-490
-13% -$34.8K
ZTS icon
122
Zoetis
ZTS
$32.4B
$236K 0.18%
1,364
+59
+5% +$9.82K
KMI icon
123
Kinder Morgan
KMI
$71.7B
$236K 0.18%
11,898
-1,431
-11% -$27.3K
STZ icon
124
Constellation Brands
STZ
$22.2B
$236K 0.18%
918
-2
-0.2% -$514
CTLT
125
DELISTED
CATALENT, INC.
CTLT
$236K 0.18%
4,198
-9
-0.2% -$502

Similar funds

Vantage Consulting Group's Q2 2024 Portfolio in Review

As of Q2 2024, Vantage Consulting Group held 217 positions worth $135M, down 14% from $157M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Vantage Consulting Group withdrew a net $4.24M in Q2 2024, closing 26 positions and reducing 111 holdings. Its most notable exit was Moderna, an estimated $246K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 24% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Vantage Consulting Group opened a new position in Omnicom Group worth $316K.

  • Vantage Consulting Group's largest Q2 2024 buy was Omnicom Group: 3,519 shares worth $316K.
  • Vantage Consulting Group added most to Syntax Stratified LargeCap ETF in Q2 2024, an estimated $274K increase.
  • Vantage Consulting Group's biggest Q2 2024 reduction was NRG Energy, cutting an estimated $179K.
  • Vantage Consulting Group fully exited Moderna in Q2 2024, selling an estimated $246K.
  • Vantage Consulting Group's ten largest holdings make up 60% of its $135M portfolio in Q2 2024.
  • Vantage Consulting Group opened 5 new positions and closed 26 in Q2 2024.
  • Vantage Consulting Group's portfolio value fell 14% quarter-over-quarter to $135M.

Based on Vantage Consulting Group's 13F filing for Q2 2024, filed 14 Aug 2024.